Surgical Outcome After Pancreatoduodenectomy for Duodenal Adenocarcinoma Compared with Other Periampullary Cancers: A Nationwide Audit Study

• Published in: Annals of surgical oncology Vol. 30; no. 4; pp. 2448 - 2455
• Main Authors: de Bakker, Jacob K., Suurmeijer, J. Annelie, Toennaer, Jurgen G. J., Bonsing, Bert A., Busch, Olivier R., van Eijck, Casper H., de Hingh, Ignace H., de Meijer, Vincent E., Molenaar, I. Quintus, van Santvoort, Hjalmar C., Stommel, Martijn W., Festen, Sebastiaan, van der Harst, Erwin, Patijn, Gijs, Lips, Daan J., Den Dulk, Marcel, Bosscha, Koop, Besselink, Marc G., Kazemier, Geert
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.04.2023; Springer Nature B.V
• Subjects: Adenocarcinoma; Adenocarcinoma - pathology; Adenocarcinoma - surgery; Cancer; Diagnosis; Duodenal Neoplasms - pathology; Duodenal Neoplasms - surgery; Fistula; Fistulae; Humans; Medicine; Medicine & Public Health; Mortality; Oncology; Pancreatic cancer; Pancreatic Fistula - etiology; Pancreatic Neoplasms - pathology; Pancreatic Tumors; Pancreaticoduodenectomy; Pancreaticoduodenectomy - adverse effects; Patients; Postoperative Complications - etiology; Retrospective Studies; Surgery; Surgical Oncology; Surgical outcomes; Treatment Outcome
• ISSN: 1068-9265; 1534-4681
• DOI: 10.1245/s10434-022-12701-y

Background Surgical outcome after pancreatoduodenectomy for duodenal adenocarcinoma could differ from pancreatoduodenectomy for other cancers, but large multicenter series are lacking. This study aimed to determine surgical outcome in patients after pancreatoduodenectomy for duodenal adenocarcinoma, compared with other periampullary cancers, in a nationwide multicenter cohort. Methods After pancreatoduodenectomy for cancer between 2014 and 2019, consecutive patients were included from the nationwide, mandatory Dutch Pancreatic Cancer Audit. Patients were stratified by diagnosis. Baseline, treatment characteristics, and postoperative outcome were compared between groups. The association between diagnosis and major complications (Clavien–Dindo grade III or higher) was assessed via multivariable regression analysis. Results Overall, 3113 patients, after pancreatoduodenectomy for cancer, were included in this study: 264 (8.5%) patients with duodenal adenocarcinomas and 2849 (91.5%) with other cancers. After pancreatoduodenectomy for duodenal adenocarcinoma, patients had higher rates of major complications (42.8% vs. 28.6%; p  < 0.001), postoperative pancreatic fistula (International Study Group of Pancreatic Surgery [ISGPS] grade B/C; 23.1% vs. 13.4%; p  < 0.001), complication-related intensive care admission (14.3% vs. 10.3%; p  = 0.046), re-interventions (39.8% vs. 26.6%; p  < 0.001), in-hospital mortality (5.7% vs. 3.1%; p  = 0.025), and longer hospital stay (15 days vs. 11 days; p  < 0.001) compared with pancreatoduodenectomy for other cancers. In multivariable analysis, duodenal adenocarcinoma was independently associated with major complications (odds ratio 1.14, 95% confidence interval 1.03–1.27; p  = 0.011). Conclusion Pancreatoduodenectomy for duodenal adenocarcinoma is associated with higher rates of major complications, pancreatic fistula, re-interventions, and in-hospital mortality compared with patients undergoing pancreatoduodenectomy for other cancers. These findings should be considered in patient counseling and postoperative management.